Impact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke "MonDAFIS"

Active, not recruiting

Phase N/A Results N/A

Trial Description

Investigator-initiated prospective randomized multicentre study to uncover the true burden of paroxysmal atrial fibrillation in a representative population of acute stroke patients without known atrial fibrillation.

Conditions

Interventions

  • Prolonged ECG monitoring Other
    Intervention Desc: Start of long-term ECG immediately after admission to the stroke unit by using a portable ECG recorder for a max. duration of 7 days (or hospital discharge)
    ARM 1: Kind: Experimental
    Label: prolonged ECG monitoring
    Description: Regular stroke unit treatment and diagnostic procedures according to guidelines and additional prolonged ECG monitoring
  • ECG Device
    ARM 1: Kind: Experimental
    Label: prolonged ECG monitoring
    Description: Regular stroke unit treatment and diagnostic procedures according to guidelines and additional prolonged ECG monitoring

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Diagnostic
  • Intervention: Parallel Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary Number of patients on oral anticoagulation (NOAC or VKA) 12 months No
Secondary Number of stroke patients with newly detected atrial fibrillation 7 days No

Sponsors